Insights On Drug Discovery
-
Cell-Based Bioassays For Potency Testing: From Assay Design To GMP Readiness
2/18/2026
A concise guide to designing and optimizing cell‑based bioassays for GMP readiness, emphasizing biological relevance, robustness, and strategies to reduce variability and strengthen potency data for complex therapies.
-
What FDA CRLs Reveal About E&L
2/18/2026
FDA feedback shows E&L gaps still delay approvals. This preview flags common issues — from unknown compounds to weak tox data — and offers ways to strengthen E&L approaches and cut regulatory risk.
-
From Promise To Patients: Smarter Pathways To Scale In Cell And Gene Therapy Manufacturing
2/12/2026
As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.
-
The Science Of Cell Line Development For Biologics
2/12/2026
Selecting and engineering the right cell line is not simply a technical milestone; it is a strategic decision that shapes cost of goods, development timelines, and the overall probability of success.
-
The Gateway Delivery To The Brain
1/30/2026
Nose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress.
-
Covalent Warhead Reactivity: A New Look At GSH Reactivity Assays
1/26/2026
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
Flow Chemistry For Contemporary Isotope Labeling
1/26/2026
Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications.
-
Optimizing Lentiviral Producer Cell Line Yield
12/15/2025
Producer cell lines boost lentiviral manufacturing efficiency via high-density culture, multiple harvests, and additive optimization for scalable production.
-
Patient-Centric Formulations In Pediatric Adherence
11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
Scientific Poster: Driving High-Titer Productivity And Faster Timelines
11/13/2025
Accelerated cell line development delivers high-titer biologics in weeks, supporting diverse modalities with robust analytics, scalable productivity, and proven stability across 60+ generations.